Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RNA dynamics from experimental and computational approaches.
Bussi G, Bonomi M, Gkeka P, Sattler M, Al-Hashimi HM, Auffinger P, Duca M, Foricher Y, Incarnato D, Jones AN, Kirmizialtin S, Krepl M, Orozco M, Palermo G, Pasquali S, Salmon L, Schwalbe H, Westhof E, Zacharias M. Bussi G, et al. Among authors: duca m. Structure. 2024 Sep 5;32(9):1281-1287. doi: 10.1016/j.str.2024.07.019. Structure. 2024. PMID: 39241758
Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?
Azzollini J, Capone I, Duca M, Vingiani A, Piccolo A, Agnelli L, Tamborini E, Perrone F, Peissel B, Lorenzini D, Damian S, Vernieri C, Bianchi GV, Mantiero M, Ducceschi M, Polignano M, Niger M, Nichetti F, Proto C, Brambilla M, Colombo E, Stellato M, Conca E, Busico A, Manoukian S. Azzollini J, et al. Among authors: duca m. Tumori. 2024 Sep 23:3008916241280127. doi: 10.1177/03008916241280127. Online ahead of print. Tumori. 2024. PMID: 39311051
Novel causative variants in Legius syndrome: SPRED1 Genotype spectrum expansion.
Chelleri C, Brolatti N, De Marco P, Ognibene M, Diana MC, Madia F, Duca MD, Santangelo A, Capra V, Striano P, Zara F, Scala M. Chelleri C, et al. Among authors: duca md. Am J Med Genet A. 2024 Jul 19:e63824. doi: 10.1002/ajmg.a.63824. Online ahead of print. Am J Med Genet A. 2024. PMID: 39031930
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials.
Agnelli L, Villa A, Butt F, Duca M, Guidi A, Carapezza M, Addante M, Lenoci G, O'Regan P, Russo L, Cresta S, Castano A, Ebrahem E, Alfieri S, Patil A, Carter L, Dive C, De Braud FG, Damian S. Agnelli L, et al. Among authors: duca m. Tumori. 2024 Oct;110(5):304-308. doi: 10.1177/03008916241248007. Epub 2024 Apr 27. Tumori. 2024. PMID: 38676437 Free article.
Educational needs and career development of young epileptologists in Italy.
Spagnoli C, Duca M, Pelliccia V, Lanzone J, Masnada S, Chiarello D, Barco TL, Dono F, Nucera B. Spagnoli C, et al. Among authors: duca m. Epilepsia Open. 2024 Apr;9(2):613-625. doi: 10.1002/epi4.12888. Epub 2024 Feb 22. Epilepsia Open. 2024. PMID: 38386334 Free PMC article.
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.
Rivoltini L, Camisaschi C, Fucà G, Paolini B, Vergani B, Beretta V, Damian S, Duca M, Cresta S, Magni M, Leone BE, Castelli C, de Braud F, De Santis F, Di Nicola M. Rivoltini L, et al. Among authors: duca m. Sci Rep. 2024 Feb 9;14(1):3379. doi: 10.1038/s41598-024-54041-9. Sci Rep. 2024. PMID: 38336861 Free PMC article. Clinical Trial.
Small molecule approaches to targeting RNA.
Kovachka S, Panosetti M, Grimaldi B, Azoulay S, Di Giorgio A, Duca M. Kovachka S, et al. Among authors: duca m. Nat Rev Chem. 2024 Feb;8(2):120-135. doi: 10.1038/s41570-023-00569-9. Epub 2024 Jan 26. Nat Rev Chem. 2024. PMID: 38278932 Review.
276 results